Diabetic foot attack: Managing severe sepsis in the diabetic patient.

Kisshan Raj Balakrishnan, Dharshanan Raj Selva Raj, Sabyasachi Ghosh, Gregory Aj Robertson
Author Information
  1. Kisshan Raj Balakrishnan: Department of Trauma and Orthopaedics, Wrexham Maelor Hospital, Wrexham LL13 7TD, United Kingdom. kisshan.raj1108@gmail.com.
  2. Dharshanan Raj Selva Raj: Department of Trauma and Orthopaedics, Wrexham Maelor Hospital, Wrexham LL13 7TD, United Kingdom.
  3. Sabyasachi Ghosh: Department of Trauma and Orthopaedics, Wrexham Maelor Hospital, Wrexham LL13 7TD, United Kingdom.
  4. Gregory Aj Robertson: Department of Trauma and Orthopaedics, Wrexham Maelor Hospital, Wrexham LL13 7TD, United Kingdom.

Abstract

Diabetic foot attack (DFA) is the most severe presentation of Diabetic foot disease, with the patient commonly displaying severe sepsis, which can be limb or life threatening. DFA can be classified into two main categories: Typical and atypical. A typical DFA is secondary to a severe infection in the foot, often initiated by minor breaches in skin integrity that allow pathogens to enter and proliferate. This form often progresses rapidly due to the underlying Diabetic pathophysiology of neuropathy, microvascular disease, and hyperglycemia, which facilitate infection spread and tissue necrosis. This form of DFA can present as one of a number of severe infective pathologies including pyomyositis, necrotizing fasciitis, and myonecrosis, all of which can lead to systemic sepsis and multi-organ failure. An atypical DFA, however, is not primarily infection-driven. It can occur secondary to either ischemia or Charcot arthropathy. Management of the typical DFA involves prompt diagnosis, aggressive infection control, and a multidisciplinary approach. Treatment can be guided by the current International Working Group on the Diabetic Foot/Infectious Diseases Society of America guidelines on Diabetic foot infections, and the combined British Orthopaedic Foot and Ankle Society-Vascular Society guidelines. This article highlights the importance of early recognition, comprehensive management strategies, and the need for further research to establish standardized protocols and improve clinical outcomes for patients with DFA.

Keywords

References

  1. Infect Dis (Lond). 2016;48(1):70-3 [PMID: 26357990]
  2. Endocrinol Metab Clin North Am. 2021 Sep;50(3):415-430 [PMID: 34399954]
  3. Nat Rev Nephrol. 2018 Jul;14(7):417-427 [PMID: 29691495]
  4. Anaesthesiol Intensive Ther. 2019;51(4):299-305 [PMID: 31550871]
  5. Rev Endocr Metab Disord. 2023 Apr;24(2):221-239 [PMID: 36322296]
  6. Int J Low Extrem Wounds. 2019 Sep;18(3):279-286 [PMID: 31237147]
  7. PLoS One. 2024 May 7;19(5):e0302167 [PMID: 38713690]
  8. Int J Mol Sci. 2019 Oct 29;20(21): [PMID: 31671729]
  9. Yale J Biol Med. 2019 Dec 20;92(4):629-640 [PMID: 31866778]
  10. J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1633-e1641 [PMID: 37319368]
  11. J Diabetes Investig. 2016 Jul;7(4):637-640 [PMID: 27181931]
  12. Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31 [PMID: 31862745]
  13. Cureus. 2023 Jul 12;15(7):e41772 [PMID: 37575721]
  14. Int J Low Extrem Wounds. 2023 Dec;22(4):733-741 [PMID: 34488474]
  15. Clin Infect Dis. 2023 Oct 02;: [PMID: 37779457]
  16. Clin Infect Dis. 2012 Jun;54(12):e132-73 [PMID: 22619242]
  17. Nat Rev Immunol. 2013 Dec;13(12):862-74 [PMID: 24232462]
  18. Cleve Clin J Med. 2020 Jan;87(1):53-64 [PMID: 31990655]
  19. Nursing. 2024 Jun 1;54(6):39-40 [PMID: 38757995]
  20. J Am Acad Orthop Surg. 2024 Jan 15;32(2):51-58 [PMID: 37755401]
  21. Diabetologia. 2012 Nov;55(11):2906-12 [PMID: 22890823]
  22. Ulus Travma Acil Cerrahi Derg. 2023 Oct;29(10):1122-1129 [PMID: 37791449]
  23. World J Orthop. 2024 May 18;15(5):404-417 [PMID: 38835689]
  24. Wound Repair Regen. 2015 Sep;23(5):737-44 [PMID: 26100572]
  25. J Cardiovasc Nurs. 2002 Jan;16(2):17-23 [PMID: 11800065]
  26. Plast Reconstr Surg. 2006 Jun;117(7 Suppl):212S-238S [PMID: 16799390]
  27. Foot (Edinb). 2019 Jun;39:22-27 [PMID: 30878011]
  28. Diabet Med. 2020 Feb;37(2):242-247 [PMID: 31901175]
  29. Ther Clin Risk Manag. 2017 Apr 18;13:533-544 [PMID: 28458556]
  30. BMC Public Health. 2024 May 9;24(1):1274 [PMID: 38724956]
  31. Arch Cardiol Mex. 2023;93(1):30-36 [PMID: 36757785]
  32. Diabet Med. 2012 Jul;29(7):855-62 [PMID: 22537247]
  33. J Clin Orthop Trauma. 2021 Apr 24;18:114-120 [PMID: 33996456]
  34. J Epidemiol Community Health. 2009 Apr;63(4):332-6 [PMID: 19240084]
  35. World J Diabetes. 2015 Jun 25;6(6):850-67 [PMID: 26131326]
  36. Exp Clin Endocrinol Diabetes. 2024 Mar;132(3):112-124 [PMID: 38378016]
  37. Cells. 2024 Feb 27;13(5): [PMID: 38474378]
  38. J Diabetes Complications. 2007 Nov-Dec;21(6):341-9 [PMID: 17967704]
  39. Int J Low Extrem Wounds. 2018 Mar;17(1):7-13 [PMID: 29430981]
  40. Crit Care Clin. 2018 Jan;34(1):63-80 [PMID: 29149942]
  41. Crit Care Med. 2021 Sep 1;49(9):1576-1582 [PMID: 34413272]
  42. Am J Hematol. 2010 Jan;85(1):71-4 [PMID: 19802882]
  43. Adv Wound Care (New Rochelle). 2015 Sep 1;4(9):560-582 [PMID: 26339534]
  44. J Orthop. 2019 Aug 13;17:173-179 [PMID: 31879500]
  45. Lancet Diabetes Endocrinol. 2017 Jun;5(6):404-405 [PMID: 28456417]
  46. Medicina (B Aires). 2020;80(5):523-530 [PMID: 33048798]
  47. Cochrane Database Syst Rev. 2015 Jun 24;(6):CD004123 [PMID: 26106870]
  48. Am Fam Physician. 2020 Apr 1;101(7):409-418 [PMID: 32227831]
  49. Diabetes Res Clin Pract. 2024 May;211:111666 [PMID: 38616041]
  50. Ostomy Wound Manage. 2006 Jun;52(6):68-70, 72, 74 passim [PMID: 16799184]

Word Cloud

Created with Highcharts 10.0.0footDFAcanDiabeticseverediabeticsepsisinfectionattackdiseasepatientatypicaltypicalsecondaryoftenformSocietyguidelinespresentationcommonlydisplayinglimblifethreateningclassifiedtwomaincategories:Typicalinitiatedminorbreachesskinintegrityallowpathogensenterproliferateprogressesrapidlydueunderlyingpathophysiologyneuropathymicrovascularhyperglycemiafacilitatespreadtissuenecrosispresentonenumberinfectivepathologiesincludingpyomyositisnecrotizingfasciitismyonecrosisleadsystemicmulti-organfailurehoweverprimarilyinfection-drivenoccureitherischemiaCharcotarthropathyManagementinvolvespromptdiagnosisaggressivecontrolmultidisciplinaryapproachTreatmentguidedcurrentInternationalWorkingGroupFoot/InfectiousDiseasesAmericainfectionscombinedBritishOrthopaedicFootAnkleSociety-Vasculararticlehighlightsimportanceearlyrecognitioncomprehensivemanagementstrategiesneedresearchestablishstandardizedprotocolsimproveclinicaloutcomespatientsattack:ManagingDiabetesmellitusSepsisSystemic

Similar Articles

Cited By

No available data.